首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1764873

2031 年北美器官保存解决方案市场预测 - 区域分析 - 按产品、应用、类型和最终用户

North America Organ Preservation Solution Market Forecast to 2031 - Regional Analysis - by Product, Application, Type, and End User

出版日期: 2025年04月17日 | 出版商:

The Insight Partners | 英文 140 Pages | 订单完成后即时交付

价格

简介目录图表

2023 年北美器官保存液市场价值为 1,23,239.05 千美元，预计到 2031 年将达到 2,26,118.82 千美元；预计 2024 年至 2031 年的复合年增长率为 8.0%。

器官移植需求不断成长，推动北美器官保存解决方案市场

已知有多种慢性疾病会损害心臟、肺、肝、肾和其他器官的功能。不良饮食会导致肾臟和肝臟疾病，进而导致器官衰竭。例如，全球约有 10% 的人口患有慢性肾臟病。根据美国卫生与公共服务部的数据，估计美国超过七分之一（即约 15% 或约 3.7 万名成年人）患有慢性肾臟病。此外，过量饮酒会导致肝硬化，因此需要进行肝臟移植。移植接受者科学登记处 (SRTR) 报告称，无论心臟衰竭的药物治疗是否成功，符合新心臟移植条件的候选人数量都在持续增加。 COVID-19 疫情对新登记名单产生了一定影响。在 2018 年至 2020 年保持平稳，2020 年略有下降（从 2019 年的 4,087 例下降到 2020 年的 4,000 例）之后，2021 年新发心臟衰竭病例数增加到 4,373 例。移植手术在世界各地变得越来越普遍。 2023 年，器官共享联合网络报告称，美国进行了超过 46,000 例器官移植，比 2022 年增长了 8.7% 以上。此外，美国历史上首次进行了 27,000 例肾臟移植。等待器官移植的患者通常患有末期器官疾病，这会严重影响他们的生活质量，并可能表明他们已接近生命的终点。末期器官衰竭患者数量的增加引发了及时器官移植的需求。由于移植技术的进步，更多这样的人现在有资格接受器官移植。器官保存液用于在一定时期内维持器官的活力和功能，以便将其运输并随后移植到接受者体内。器官移植的成功主要取决于器官保存、手术、免疫治疗和术后照护。因此，器官移植需求的不断增长推动了器官保存液市场的成长。

北美器官保存解决方案市场概览

北美器官保存解决方案市场细分为美国、加拿大和墨西哥。技术先进产品和解决方案的日益普及，以及器官移植数量的激增，是该地区器官保存解决方案市场的受益因素。美国是全球最大的器官保存解决方案市场，预计在预测期内将占据全球市场的主导地位。美国市场的成长归因于美国慢性肾臟病 (CKD) 盛行率的上升和老年人口的增加。根据美国国家慢性肾臟病说明书，2021 年美国约有 3.7 万人患有慢性肾臟病。

2024 年 6 月，美国肾臟基金会报告称，多达 3.7 万美国人患有肾臟疾病，约 80.8 万美国人受到肾衰竭的影响。超过 55.7 万美国人正在接受透析治疗。肾臟疾病的盛行率正在上升，目前影响到超过七分之一（或 14%）的美国成年人。 2021 年，约有 13.5 万美国人被新诊断出患有肾衰竭。此外，十分之九的肾臟疾病患者并不知道自己患有肾臟疾病，三分之一的肾功能严重下降的患者也不知道自己患有肾臟疾病。此外，根据同一消息来源，超过 25 万美国人接受了肾臟移植，超过 9.3 万美国人在肾臟移植等候名单上。 2023 年，只有 27,332 人接受了肾臟移植，其中 6,290 人来自活体捐赠者。美国食品药物管理局 (FDA) 批准数量的增加以及市场参与者的存在推动了美国器官保存解决方案市场的成长。 2022 年 4 月，TransMedics Group, Inc. 宣布其 OCS 心臟系统已获得 FDA 上市前批准，该系统可用于循环死亡 (DCD) 后捐赠者的器官。 OCS 心臟系统已被批准用于体外復活、功能监测和循环死亡 (DCD) 后捐赠心臟的跳动保存。因此，器官移植需求的增加推动了美国器官保存解决方案市场的发展。美国的器官保存解决方案製造商推出用于器官运输的设备。 2023 年 8 月，领先的器官移植公司 Paragonix Technologies 的下一代供肺保存系统 BAROguard 获得了 FDA 批准。该系统将 Paragonix 先进的低温保存技术与自动持续主动式气道压力控制相结合。这确保了捐赠者肺部从捐赠者到接受者的整个过程中，始终保持最佳温度范围和临床建议的充气压力范围。这种新颖的先进技术组合强化了公司持续致力于改进和重新定义移植医学护理标准的承诺。

北美器官保存解决方案市场收入及预测（2031 年）（千美元）

北美器官保存解决方案市场细分

北美器官保存解决方案市场分为产品、应用、类型、最终用户和国家。

根据产品类型，北美器官保存液市场分为威斯康辛大学溶液、custodiol HTK、Perfadex、HypoThermosol 等。威斯康辛大学溶液在2023年占据了最大的市场份额。

从应用角度来看，北美器官保存液市场细分为静态冷藏、低温机械灌注、常温机械灌注等。静态冷藏领域在2023年占据了最大的市场。

依类型划分，北美器官保存液市场分为肾臟、肝臟、肺臟、心臟和其他器官。肾臟器官在2023年占据了最大的市场。

根据最终用户，北美器官保存解决方案市场细分为器官移植中心、医院和专科诊所。器官移植中心在2023年占据了最大的市场。

依国家划分，北美器官保存液市场分为美国、加拿大和墨西哥。 2023年，美国占据了北美器官保存液市场的主导地位。

Waters Medical Systems LLC、XVIVO Perfusion、TransMedics、OrganOx Limited、Paragonix Technologies, Inc、Dr. Franz Koehler Chemie GmbH、Accord Healthcare、21ST Century Medicine 和 Bridge to Life Ltd. 是北美器官保存解决方案市场领先的公司。

Several chronic diseases are known to damage the functioning of the heart, lungs, liver, kidney, and other organs. A poor diet contributes to the development of renal and hepatic illnesses, which can also lead to organ failure. For instance, around 10% of the global population is impacted by chronic kidney disease. According to the US Department of Health & Human Services, more than 1 in 7 (i.e., ~15% or ~37 thousand adults) are estimated to have chronic kidney disease in the US. Further, excessive alcohol consumption leads to liver cirrhosis, resulting in the need for a liver transplant. The Scientific Registry of Transplant Recipients (SRTR) reports that irrespective of the success of medical treatments for heart failure, the number of candidates eligible for new heart transplants continues to rise. The COVID-19 pandemic had some impact on new listings. After a plateau from 2018 through 2020 and a slight decrease in 2020 (from 4,087 in 2019 to 4,000 in 2020), the number of new heart failure cases increased to 4,373 in 2021. Transplantation surgeries are becoming more common worldwide. In 2023, the United Network for Organ Sharing reported a record of more than 46,000 organ transplants in the US, marking an increase of over 8.7% from 2022. Additionally, the country crossed the mark of 27,000 kidney transplants for the first time in its history. Patients who are on the organ waiting list typically suffer from end-stage organ disease, which significantly affects their quality of life and may indicate that they are nearing the end of their life. The rising number of individuals with end-stage organ failure triggers the need for timely organ transplantation. Due to advancements in transplantation techniques, more such people are now eligible for organ transplants. Organ preservation solutions are used to maintain the viability and function of organs for a certain period, allowing for their transport and subsequent transplantation into a recipient. The success of organ transplantation is primarily determined by organ preservation, surgery, immunotherapy, and post-operative care. Thus, a rising demand for organ transplantation drives the organ preservation solution market toward growth.

North America Organ Preservation Solution Market Overview

The North America organ preservation solution market is segmented into the US, Canada, and Mexico. Increasing adoption of technologically advanced products and solutions, and surging number of organ transplants are the factors benefiting the organ preservation solution market in this region. The US is the largest organ preservation solution market across the world and is estimated to dominate the global market during the forecast period. The US market growth is attributed to the rising chronic kidney diseases (CKD) prevalence and the increasing geriatric population in the US. According to the National Chronic Kidney Disease fact sheet, ~37 thousand people in the US were suffering from chronic kidney diseases in 2021.

In June 2024, the American Kidney Fund, Inc. reported that up to 37 thousand Americans have kidney disease, and ~808,000 Americans are affected by kidney failure. More than 557,000 Americans are undergoing dialysis treatment. The prevalence of kidney disease is rising and currently affects over 1 in 7 (or 14%) of American adults. In 2021, around 135,000 Americans were newly diagnosed with kidney failure. Also, 9 out of 10 people affected by kidney disease are unaware they have it, and 1 in 3 of people with severely reduced kidney function are also unaware they have kidney disease. Furthermore, as per the same source stated that more than 250,000 Americans have undergone kidney transplants, and there are over 93,000 Americans on the kidney transplant waiting list. In 2023, only 27,332 people received kidney transplants, with 6,290 of those from living donors. The rising number of approvals from the US Food and Drug Administration (FDA) and the presence of market players in the country boost the US organ preservation solution market growth. In April 2022, TransMedics Group, Inc. announced that it received premarket FDA approval for its OCS Heart System, which can be used with organs from donors after circulatory death (DCD). The OCS Heart System is approved with the extended clinical indication for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death (DCD) hearts. Thus, the rising need for organ transplantation drives the organ preservation solutions market in the US. Organ preservation solution manufacturers in the US launch devices used for organ transportation. In August 2023, Paragonix Technologies, a leading organ transplant company, received FDA clearance for its next-generation donor lung preservation system, BAROguard. The system combines Paragonix's advanced hypothermic preservation technology with automated continuous and active airway pressure control. This ensures that an optimal temperature range and a clinically recommended inflation pressure range for donor lungs are maintained throughout the journey from the donor to the recipient patient. This novel combination of advanced technologies reinforces the company's ongoing commitment to improving and redefining the standard of care within transplant medicine.

North America Organ Preservation Solution Market Revenue and Forecast to 2031 (US$ Thousand)

North America Organ Preservation Solution Market Segmentation

The North America organ preservation solution market is categorized into product, application, type, end user, and country.

Based on product, the North America organ preservation solution market is categorized into University of Wisconsin solution, custodiol HTK, Perfadex, HypoThermosol, and others. The University of Wisconsin segment held the largest market share in 2023.

In terms of application, the North America organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held the largest market share in 2023.

By type, the North America organ preservation solution market is categorized into kidneys, liver, lungs, heart, and others. The kidneys segment held the largest market share in 2023.

Based on end user, the North America organ preservation solution market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment held the largest market share in 2023.

By country, the North America organ preservation solution market is segmented into the US, Canada, and Mexico. The US dominated the North America organ preservation solution market share in 2023.

Waters Medical Systems LLC, XVIVO Perfusion, TransMedics, OrganOx Limited, Paragonix Technologies, Inc, Dr. Franz Koehler Chemie GmbH, Accord Healthcare, 21ST Century Medicine, and Bridge to Life Ltd., are among the leading companies operating in the North America organ preservation solution market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. North America Organ Preservation Solution Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rising Need for Organ Transplantation
- 4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
- 4.2.1 Expensive Organ Transplant Surgeries
- 4.2.2 Limited Organ Availability
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives by Market Players
4.4 Future Trends
- 4.4.1 Shift Toward Machine Perfusion Technique
4.5 Impact of Drivers and Restraints:

5. Organ Preservation Solution Market - North America Analysis

5.1 Organ Preservation Solution Market Revenue (US$ Thousand), 2021-2031
5.2 Organ Preservation Solution Market forecast Analysis

6. North America Organ Preservation Solution Market Analysis - by Product

6.1 University of Wisconsin Solution
- 6.1.1 Overview
- 6.1.2 University of Wisconsin Solution: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
6.2 Custodiol HTK
- 6.2.1 Overview
- 6.2.2 Custodiol HTK: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
6.3 Perfadex
- 6.3.1 Overview
- 6.3.2 Perfadex: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
6.4 HypoThermosol
- 6.4.1 Overview
- 6.4.2 HypoThermosol: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
6.5 Others
- 6.5.1 Overview
- 6.5.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

7. North America Organ Preservation Solution Market Analysis - by Application

7.1 Static Cold Storage
- 7.1.1 Overview
- 7.1.2 Static Cold Storage: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
7.2 Hypothermic Machine Perfusion
- 7.2.1 Overview
- 7.2.2 Hypothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
7.3 Normothermic Machine Perfusion
- 7.3.1 Overview
- 7.3.2 Normothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

8. North America Organ Preservation Solution Market Analysis - by Type

8.1 Kidneys
- 8.1.1 Overview
- 8.1.2 Kidneys: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
8.2 Liver
- 8.2.1 Overview
- 8.2.2 Liver: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
8.3 Lungs
- 8.3.1 Overview
- 8.3.2 Lungs: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
8.4 Heart
- 8.4.1 Overview
- 8.4.2 Heart: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

9. North America Organ Preservation Solution Market Analysis - by End User

9.1 Organ Transplant Centers
- 9.1.1 Overview
- 9.1.2 Organ Transplant Centers: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
9.2 Hospitals
- 9.2.1 Overview
- 9.2.2 Hospitals: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
9.3 Specialty Clinics
- 9.3.1 Overview
- 9.3.2 Specialty Clinics: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

10. North America Organ Preservation Solution Market - Country Analysis

10.1 North America Organ Preservation Solution Market Overview
- 10.1.1 North America: Organ Preservation Solution Market Breakdown, by Key Country, 2023 and 2031 (%)
  - 10.1.1.1 North America: Organ Preservation Solution Market - Revenue and forecast Analysis - by Country
  - 10.1.1.2 United States: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
    - 10.1.1.2.1 United States: Organ Preservation Solution Market Breakdown, by Product
    - 10.1.1.2.2 United States: Organ Preservation Solution Market Breakdown, by Application
    - 10.1.1.2.3 United States: Organ Preservation Solution Market Breakdown, by Type
    - 10.1.1.2.4 United States: Organ Preservation Solution Market Breakdown, by End User
  - 10.1.1.3 Canada: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
    - 10.1.1.3.1 Canada: Organ Preservation Solution Market Breakdown, by Product
    - 10.1.1.3.2 Canada: Organ Preservation Solution Market Breakdown, by Application
    - 10.1.1.3.3 Canada: Organ Preservation Solution Market Breakdown, by Type
    - 10.1.1.3.4 Canada: Organ Preservation Solution Market Breakdown, by End User
  - 10.1.1.4 Mexico: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
    - 10.1.1.4.1 Mexico: Organ Preservation Solution Market Breakdown, by Product
    - 10.1.1.4.2 Mexico: Organ Preservation Solution Market Breakdown, by Application
    - 10.1.1.4.3 Mexico: Organ Preservation Solution Market Breakdown, by Type
    - 10.1.1.4.4 Mexico: Organ Preservation Solution Market Breakdown, by End User

11. Organ Preservation Solutions Market - Industry Landscape

11.1 Overview
11.2 Growth Strategies in Organ Preservation Solutions Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Waters Medical Systems LLC
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 XVIVO Perfusion
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 TransMedics
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 OrganOx Limited
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Paragonix Technologies, Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Dr. Franz Koehler Chemie GmbH
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Accord Healthcare
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8st Century Medicine
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Bridge to Life Ltd
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. North America Organ Preservation Solution Market Segmentation
Table 2. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Table 3. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
Table 4. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
Table 5. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
Table 6. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
Table 7. North America: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Country
Table 8. United States: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
Table 9. United States: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
Table 10. United States: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
Table 11. United States: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
Table 12. Canada: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
Table 13. Canada: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
Table 14. Canada: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
Table 15. Canada: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
Table 16. Mexico: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
Table 17. Mexico: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
Table 18. Mexico: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
Table 19. Mexico: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
Table 20. Recent Organic Growth Strategies in Organ Preservation Solutions Market
Table 21. Recent Inorganic Growth Strategies in the Organ Preservation Solutions Market
Table 22. Glossary of Terms, Organ Preservation Solution Market

List Of Figures

Figure 1. North America Organ Preservation Solution Market Segmentation, by Country
Figure 2. Organ Preservation Solution Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Organ Preservation Solution Market Revenue (US$ Thousand), 2021-2031
Figure 5. Organ Preservation Solution Market Share (%) - by Product (2023 and 2031)
Figure 6. University of Wisconsin Solution: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 7. Custodiol HTK: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 8. Perfadex: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 9. HypoThermosol: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 10. Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 11. Organ Preservation Solution Market Share (%) - by Application (2023 and 2031)
Figure 12. Static Cold Storage: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 13. Hypothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 14. Normothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 15. Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 16. Organ Preservation Solution Market Share (%) - by Type (2023 and 2031)
Figure 17. Kidneys: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 18. Liver: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 19. Lungs: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 20. Heart: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 21. Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 22. Organ Preservation Solution Market Share (%) - by End User (2023 and 2031)
Figure 23. Organ Transplant Centers: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 24. Hospitals: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 25. Specialty Clinics: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 26. North America Organ Preservation Solution Market, by Key Country - Revenue (2023) (US$ Thousand)
Figure 27. North America: Organ Preservation Solution Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 28. United States: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 29. Canada: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 30. Mexico: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 31. Growth Strategies in Organ Preservation Solutions Market